Publications found:
73,128
Sort by:
Bone Metastasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bone Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bone Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
124 pages
Klebsiella pneumoniae Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
140 pages
Hairy Cell Leukemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hairy Cell Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hairy Cell Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
137 pages
Acinetobacter Infections - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acinetobacter Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Acinetobacter Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
204 pages
Haemophilus influenzae Type B Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Haemophilus influenzae Type B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Haemophilus influenzae Type B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
72 pages
Low Back Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
138 pages
Neurofibromatoses Type II - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neurofibromatoses Type II (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type II and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
62 pages
Binge Eating Disorder - Pipeline Review, H2 2020
US$ 2,000.00
... . The Binge Eating Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
48 pages
Narcolepsy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Narcolepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Narcolepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
100 pages
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chagas Disease (American Trypanosomiasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
90 pages
Epidermolysis Bullosa - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Epidermolysis Bullosa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Epidermolysis Bullosa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
170 pages
Neisseria meningitidis Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Neisseria meningitidis Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
95 pages
Cataract - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cataract (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Cataract and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
46 pages
Inclusion Body Myositis (IBM) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Inclusion Body Myositis (IBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
73 pages
Guillain-Barre Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Guillain-Barre Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Guillain-Barre Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
84 pages
Epigenetics Market by Product (Kits, Reagents, Enzymes, and Instruments), Application (Oncology and Non-Oncology), and End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
... of emerging markets provides lucrative opportunities to the market players. The epigenetics market is segmented based on product, application, end user, and geography. Based on product, it is divided into enzymes, kits ...
October 2020
291 pages
Chikungunya Fever - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
132 pages
Kidney Transplant Rejection - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Kidney Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
191 pages
Rett Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Rett Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Rett Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
178 pages
Hepatitis A - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hepatitis A (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis A and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
34 pages
Behcet Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Behcet Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Behcet Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
68 pages
Hypertrophic Cardiomyopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypertrophic Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Hypertrophic Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
102 pages
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2020
US$ 2,500.00
... -Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
94 pages
Ventricular Tachycardia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ventricular Tachycardia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ventricular Tachycardia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
47 pages
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
57 pages
Gastric Inhibitory Polypeptide Receptor - Pipeline Review, H2 2020
US$ 3,500.00
... Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
October 2020
56 pages
Parkinson's Disease - Pipeline Review, H2 2020
US$ 2,500.00
Parkinson's Disease - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Pipeline Review, H2 2020, provides an o...
October 2020
1308 pages
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 SUMMARY 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) - The 5-HT6 receptor is a subtype of 5-HT receptor that binds t...
October 2020
62 pages
Cathepsin B - Pipeline Review, H2 2020
US$ 3,500.00
Cathepsin B - Pipeline Review, H2 2020 SUMMARY Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecul...
October 2020
33 pages
Cathepsin L1 - Pipeline Review, H2 2020
US$ 3,500.00
Cathepsin L1 - Pipeline Review, H2 2020 SUMMARY Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a lysosomal endopeptidase is a member of the papain-like fam...
October 2020
36 pages
Coagulation Factor XI - Pipeline Review, H2 2020
US$ 3,500.00
Coagulation Factor XI - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Coagulation Factor XI - Pipeline Review, H2 2020'; Coagulation Factor XI (Plasma Thromboplastin Ant...
October 2020
71 pages
Collagenase 3 - Pipeline Review, H2 2020
US$ 3,500.00
Collagenase 3 - Pipeline Review, H2 2020 SUMMARY Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close to 5 molecules. Out of which approximately 4 molec...
October 2020
62 pages
Estrogen Receptor Beta - Pipeline Review, H2 2020
US$ 3,500.00
Estrogen Receptor Beta - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Pipeline Review, H2 2020'; Estrogen Receptor Beta (ER Beta or Nuclear Rec...
October 2020
79 pages
Free Fatty Acid Receptor 1 - Pipeline Review, H2 2020
US$ 3,500.00
Free Fatty Acid Receptor 1 - Pipeline Review, H2 2020 SUMMARY Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Free fatty acid receptor 1 (FFA1), also known as GPR40, is...
October 2020
69 pages
Histamine H4 Receptor - Pipeline Review, H2 2020
US$ 3,500.00
Histamine H4 Receptor - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Histamine H4 Receptor - Pipeline Review, H2 2020'; Histamine H4 Receptor (AXOR35 or G Protein Coupl...
October 2020
48 pages
Histone Deacetylase 1 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 1 - Pipeline Review, H2 2020 SUMMARY Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) pipeline Target constitutes close to 38 molecules. Out of which approximately 30 molecules are dev...
October 2020
178 pages
Histone Deacetylase 2 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 2 - Pipeline Review, H2 2020 SUMMARY Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Histone deacetylase 2 is an...
October 2020
159 pages
Histone Deacetylase 3 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 3 - Pipeline Review, H2 2020 SUMMARY Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) pipeline Target constitutes close to 19 molecules. Out of which approximately...
October 2020
115 pages
Histone Deacetylase 6 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 6 - Pipeline Review, H2 2020 SUMMARY Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Histone deacetylase 6 is an enzyme encoded by the...
October 2020
149 pages
Huntingtin - Pipeline Review, H2 2020
US$ 3,500.00
Huntingtin - Pipeline Review, H2 2020 SUMMARY Huntingtin (Huntington Disease Protein or HTT) - Huntingtin protein is an encoded by the huntingtin gene, also called the HTT or HD (Huntington disease) g...
October 2020
93 pages
Lysophosphatidic Acid Receptor 1 - Pipeline Review, H2 2020
US$ 3,500.00
Lysophosphatidic Acid Receptor 1 - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Lysophosphatidic Acid Receptor 1 - Pipeline Review, H2 2020'; Lysophosphatidic Acid Rece...
October 2020
37 pages
Matrix Metalloproteinase 9 - Pipeline Review, H2 2020
US$ 3,500.00
Matrix Metalloproteinase 9 - Pipeline Review, H2 2020 SUMMARY Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) - Matrix metallopepti...
October 2020
53 pages
Melanocortin Receptor 4 - Pipeline Review, H2 2020
US$ 3,500.00
Melanocortin Receptor 4 - Pipeline Review, H2 2020 SUMMARY Melanocortin Receptor 4 (MC4R) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by co...
October 2020
83 pages
